13F Pro

SEC Form 4 reporting owner

Meeker David P

Meeker David P has filed 15 Form 4 transactions reported between February 1, 2026 and September 14, 2026, as President and CEO of RHYTHM PHARMACEUTICALS, INC., a reporting owner of Kardigan, Inc. and a reporting owner of Trevi Therapeutics, Inc..

Name as filed: Meeker David P

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$5.1M
5 lines
Companies
3
with Form 4 filings
Latest transaction
Sep 14, 2026
transaction date

Roles and reported holdings

  • RYTMRHYTHM PHARMACEUTICALS, INC.
    Feb 1, 2026 – Sep 14, 2026

    President and CEO

    Held directly239,258 sh as of Sep 14, 2026 · Form 4

    24 months: $5.1M sold

  • KARDKardigan, Inc.
    Jun 17, 2026

    Reporting owner

    No common-stock holding reported on a purchase, sale, gift or withholding line.

  • TRVITrevi Therapeutics, Inc.
    Jun 3, 2026

    Reporting owner

    No common-stock holding reported on a purchase, sale, gift or withholding line.

Transaction history

All 15 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 14, 2026RYTMPresident and CEOOpen-market saleCode S · direct2,300$242K@ $105.19Form 4
Sep 14, 2026RYTMPresident and CEOOpen-market saleCode S · direct1,817$190K@ $104.55Form 4
Sep 14, 2026RYTMPresident and CEOOpen-market saleCode S · direct8,698$900K@ $103.43Form 4
Sep 14, 2026RYTMPresident and CEOOpen-market saleCode S · direct30,746$3.1M@ $102.35Form 4
Sep 14, 2026RYTMPresident and CEOOpen-market saleCode S · direct6,439$655K@ $101.75Form 4
Sep 14, 2026RYTMPresident and CEOOption exerciseCode M · direct50,000$303K@ $6.05Form 4
Jun 17, 2026KARDGrant or awardCode A · direct20,706—Form 4
Jun 3, 2026TRVIGrant or awardCode A · direct35,000—Form 4
Feb 11, 2026RYTMPresident and CEOGrant or awardCode A · direct107,850—Form 4
Feb 11, 2026RYTMPresident and CEOGrant or awardCode A · direct71,900—Form 4
Feb 1, 2026RYTMPresident and CEOOption exerciseCode M · direct33,338—Form 4
Feb 1, 2026RYTMPresident and CEOOption exerciseCode M · direct21,250—Form 4
Feb 1, 2026RYTMPresident and CEOOption exerciseCode M · direct14,125—Form 4
Feb 1, 2026RYTMPresident and CEOShares withheld for tax or exercise priceCode F · direct31,522$3.4M@ $108.99Form 4
Feb 1, 2026RYTMPresident and CEOOption exerciseCode M · direct68,713—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.